Table of Content

Global Omeprazole Market

1. Report Overview
1.1. Global Omeprazole Market Overview
1.2. Why You Should Read This Report
1.3. How This Report Delivers
1.4. Key Questions Answered by This Analytical Report
1.5. Who is This Report For?
1.6. Methodology
1.6.1. Primary Research
1.6.2. Secondary Research
1.6.3. Market Evaluation & Forecasting Methodology

2. Introduction to the Omeprazole Market
2.1. Omeprazole Market Structure
2.2. Omeprazole Market Definition
2.3. Global Omeprazole Market Taxonomy
2.4. Global Omeprazole Market Snapshot
2.5. Global Omeprazole Market Dynamics
2.5.1. Global Omeprazole Market: Driver
2.5.2. Global Omeprazole Market: Restraints
2.5.1. Global Omeprazole Market: Trends
2.5.1. Global Omeprazole Market: Opportunities

3. Global Omeprazole Market, By Dosage Form, 2019-2027
3.1. Introduction
3.2. Global Omeprazole Market Size and Forecast, By Dosage Form
3.2.1. Capsule Segment
3.2.2. Tablet Segment
3.2.3. Powder Segment

4. Global Omeprazole Market, By Distribution Channel, 2019-2027
4.1. Introduction
4.2. Global Omeprazole Market Size and Forecast, By Distribution Channel
4.2.1. Hospital Pharmacies Segment
4.2.2. Retail Pharmacies Segment
4.2.3. Online Pharmacies Segment

5. Global Omeprazole Market, By Indication, 2019-2027
5.1. Introduction
5.2. Global Omeprazole Market Size and Forecast, By Indication
5.2.1. Duodenal Ulcer Segment
5.2.2. Gastric Ulcer Segment
5.2.3. Gastroesophageal Reflux Disease Segment
5.2.4. Erosive Esophagitis Segment
5.2.5. Others Segment

6. Global Omeprazole Market, By Region, 2019-2027
6.1. Introduction
6.2. Global Omeprazole Market Size and Forecast, By Region
6.2.1. North America
6.2.2. Latin America
6.2.3. Europe
6.2.4. Asia Pacific
6.2.5. Middle East and Africa

7. North America Omeprazole Market Analysis and Forecast, 2019-2027
7.1. Introduction
7.1.1. North America
7.2. North America Omeprazole Market Forecast, By Country, 2019-2027
7.3. North America Omeprazole Market Forecast, By Dosage Form, 2019-2027
7.4. North America Omeprazole Market Forecast, By Distribution Channel, 2019-2027
7.5. North America Omeprazole Market Forecast, By Indication, 2019-2027

8. Latin America Omeprazole Market Analysis and Forecast, 2019-2027
8.1. Introduction
8.1.1. Latin America
8.2. Latin America Omeprazole Market Forecast, By Country, 2019-2027
8.1. Latin America Omeprazole Market Forecast, By Dosage Form, 2019-2027
8.2. Latin America Omeprazole Market Forecast, By Distribution Channel, 2019-2027
8.3. Latin America Omeprazole Market Forecast, By Indication, 2019-2027

9. Europe Omeprazole Market Analysis and Forecast, 2019-2027
9.1. Introduction
9.1.1. Europe
9.2. Europe Omeprazole Market Forecast, By Country, 2019-2027
9.3. Europe Omeprazole Market Forecast, By Dosage Form, 2019-2027
9.4. Europe Omeprazole Market Forecast, By Distribution Channel, 2019-2027
9.5. Europe Omeprazole Market Forecast, By Indication, 2019-2027

10. Asia Pacific Omeprazole Market Analysis and Forecast, 2019-2027
10.1. Introduction
10.1.1. Asia Pacific
10.2. Asia Pacific Omeprazole Market Forecast, By Country, 2019-2027
10.3. Asia Pacific Omeprazole Market Forecast, By Dosage Form, 2019-2027
10.4. Asia Pacific Omeprazole Market Forecast, By Distribution Channel, 2019-2027
10.5. Asia Pacific Omeprazole Market Forecast, By Indication, 2019-2027

11. Middle East & Africa Omeprazole Market Analysis and Forecast, 2019-2027
11.1. Introduction
11.1.1. MEA
11.2. MEA Omeprazole Market Forecast, By Country, 2019-2027
11.3. MEA Omeprazole Market Forecast, By Dosage Form, 2019-2027
11.4. MEA Omeprazole Market Forecast, By Distribution Channel, 2019-2027
11.5. MEA Omeprazole Market Forecast, By Indication, 2019-2027

12. Company Profiles
12.1. ASTRAZENECA PLC
12.1.1. Overview
12.1.2. Product Type/Service Offerings
12.1.3. Key Developments
12.1.4. SWOT Analysis
12.2. SANDOZ INTERNATIONAL GMBH
12.2.1. Overview
12.2.2. Product Type/Service Offerings
12.2.3. Key Developments: NA
12.2.4. SWOT Analysis
12.3. MYLAN N.V.
12.3.1. Overview
12.3.2. Product Type/Service Offerings
12.3.3. Key Developments: NA
12.3.4. SWOT Analysis
12.4. APOTEX, INC
12.4.1. Overview
12.4.2. Product Type/Service Offerings
12.4.3. Key Developments: NA
12.4.4. SWOT Analysis
12.5. DR. REDDY’S LABORATORIES INC
12.5.1. Overview
12.5.2. Product Type/Service Offerings
12.5.3. Key Developments
12.5.4. SWOT Analysis
12.6. IMPAX LABORATORIES, INC
12.6.1. Overview
12.6.2. Product Type/Service Offerings
12.6.3. Key Developments: NA
12.6.4. SWOT Analysis
12.7. PERRIGO COMPANY PLC
12.7.1. Overview
12.7.2. Product Type/Service Offerings
12.7.3. Key Developments
12.7.4. SWOT Analysis
12.8. SALIX PHARMACEUTICALS, INC
12.8.1. Overview
12.8.2. Product Type/Service Offerings
12.8.3. Key Developments: NA
12.8.4. SWOT Analysis
12.9. ALLERGAN PLC
12.9.1. Overview
12.9.2. Product Type/Service Offerings
12.9.3. Key Developments: NA
12.9.4. SWOT Analysis

13. Acronyms